Cargando…

Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac

Integrin αvβ3 is generously expressed by cancer cells and rapidly dividing endothelial cells. The principal ligands of the integrin are extracellular matrix proteins, but we have described a cell surface small molecule receptor on αvβ3 that specifically binds thyroid hormone and thyroid hormone anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Paul J., Glinsky, Gennadi V., Lin, Hung-Yun, Leith, John T., Hercbergs, Aleck, Tang, Heng-Yuan, Ashur-Fabian, Osnat, Incerpi, Sandra, Mousa, Shaker A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290672/
https://www.ncbi.nlm.nih.gov/pubmed/25628605
http://dx.doi.org/10.3389/fendo.2014.00240
_version_ 1782352283747483648
author Davis, Paul J.
Glinsky, Gennadi V.
Lin, Hung-Yun
Leith, John T.
Hercbergs, Aleck
Tang, Heng-Yuan
Ashur-Fabian, Osnat
Incerpi, Sandra
Mousa, Shaker A.
author_facet Davis, Paul J.
Glinsky, Gennadi V.
Lin, Hung-Yun
Leith, John T.
Hercbergs, Aleck
Tang, Heng-Yuan
Ashur-Fabian, Osnat
Incerpi, Sandra
Mousa, Shaker A.
author_sort Davis, Paul J.
collection PubMed
description Integrin αvβ3 is generously expressed by cancer cells and rapidly dividing endothelial cells. The principal ligands of the integrin are extracellular matrix proteins, but we have described a cell surface small molecule receptor on αvβ3 that specifically binds thyroid hormone and thyroid hormone analogs. From this receptor, thyroid hormone (l-thyroxine, T(4); 3,5,3′-triiodo-l-thyronine, T(3)) and tetraiodothyroacetic acid (tetrac) regulate expression of specific genes by a mechanism that is initiated non-genomically. At the integrin, T(4) and T(3) at physiological concentrations are pro-angiogenic by multiple mechanisms that include gene expression, and T(4) supports tumor cell proliferation. Tetrac blocks the transcriptional activities directed by T(4) and T(3) at αvβ3, but, independently of T(4) and T(3), tetrac modulates transcription of cancer cell genes that are important to cell survival pathways, control of the cell cycle, angiogenesis, apoptosis, cell export of chemotherapeutic agents, and repair of double-strand DNA breaks. We have covalently bound tetrac to a 200 nm biodegradable nanoparticle that prohibits cell entry of tetrac and limits its action to the hormone receptor on the extracellular domain of plasma membrane αvβ3. This reformulation has greater potency than unmodified tetrac at the integrin and affects a broader range of cancer-relevant genes. In addition to these actions on intra-cellular kinase-mediated regulation of gene expression, hormone analogs at αvβ3 have additional effects on intra-cellular protein-trafficking (cytosol compartment to nucleus), nucleoprotein phosphorylation, and generation of nuclear coactivator complexes that are relevant to traditional genomic actions of T(3). Thus, previously unrecognized cell surface-initiated actions of thyroid hormone and tetrac formulations at αvβ3 offer opportunities to regulate angiogenesis and multiple aspects of cancer cell behavior.
format Online
Article
Text
id pubmed-4290672
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-42906722015-01-27 Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac Davis, Paul J. Glinsky, Gennadi V. Lin, Hung-Yun Leith, John T. Hercbergs, Aleck Tang, Heng-Yuan Ashur-Fabian, Osnat Incerpi, Sandra Mousa, Shaker A. Front Endocrinol (Lausanne) Endocrinology Integrin αvβ3 is generously expressed by cancer cells and rapidly dividing endothelial cells. The principal ligands of the integrin are extracellular matrix proteins, but we have described a cell surface small molecule receptor on αvβ3 that specifically binds thyroid hormone and thyroid hormone analogs. From this receptor, thyroid hormone (l-thyroxine, T(4); 3,5,3′-triiodo-l-thyronine, T(3)) and tetraiodothyroacetic acid (tetrac) regulate expression of specific genes by a mechanism that is initiated non-genomically. At the integrin, T(4) and T(3) at physiological concentrations are pro-angiogenic by multiple mechanisms that include gene expression, and T(4) supports tumor cell proliferation. Tetrac blocks the transcriptional activities directed by T(4) and T(3) at αvβ3, but, independently of T(4) and T(3), tetrac modulates transcription of cancer cell genes that are important to cell survival pathways, control of the cell cycle, angiogenesis, apoptosis, cell export of chemotherapeutic agents, and repair of double-strand DNA breaks. We have covalently bound tetrac to a 200 nm biodegradable nanoparticle that prohibits cell entry of tetrac and limits its action to the hormone receptor on the extracellular domain of plasma membrane αvβ3. This reformulation has greater potency than unmodified tetrac at the integrin and affects a broader range of cancer-relevant genes. In addition to these actions on intra-cellular kinase-mediated regulation of gene expression, hormone analogs at αvβ3 have additional effects on intra-cellular protein-trafficking (cytosol compartment to nucleus), nucleoprotein phosphorylation, and generation of nuclear coactivator complexes that are relevant to traditional genomic actions of T(3). Thus, previously unrecognized cell surface-initiated actions of thyroid hormone and tetrac formulations at αvβ3 offer opportunities to regulate angiogenesis and multiple aspects of cancer cell behavior. Frontiers Media S.A. 2015-01-12 /pmc/articles/PMC4290672/ /pubmed/25628605 http://dx.doi.org/10.3389/fendo.2014.00240 Text en Copyright © 2015 Davis, Glinsky, Lin, Leith, Hercbergs, Tang, Ashur-Fabian, Incerpi and Mousa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Davis, Paul J.
Glinsky, Gennadi V.
Lin, Hung-Yun
Leith, John T.
Hercbergs, Aleck
Tang, Heng-Yuan
Ashur-Fabian, Osnat
Incerpi, Sandra
Mousa, Shaker A.
Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
title Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
title_full Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
title_fullStr Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
title_full_unstemmed Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
title_short Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
title_sort cancer cell gene expression modulated from plasma membrane integrin αvβ3 by thyroid hormone and nanoparticulate tetrac
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290672/
https://www.ncbi.nlm.nih.gov/pubmed/25628605
http://dx.doi.org/10.3389/fendo.2014.00240
work_keys_str_mv AT davispaulj cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac
AT glinskygennadiv cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac
AT linhungyun cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac
AT leithjohnt cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac
AT hercbergsaleck cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac
AT tanghengyuan cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac
AT ashurfabianosnat cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac
AT incerpisandra cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac
AT mousashakera cancercellgeneexpressionmodulatedfromplasmamembraneintegrinavb3bythyroidhormoneandnanoparticulatetetrac